Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 17 Dec 2020 for PDL BIOPHARMA, INC., €1.1M. Read the official filing
Filing timeline
BuySaleDominique Monnet
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
Dominique Monnet: trading record in brief
This profile gathers the share dealings of Dominique Monnet in PDL Biopharma, Inc. We count 8 filings; the first trade dates from 12 September 2017 and the latest from 16 December 2020.
The open-market record consists of 1 sale worth €1.1M, with no purchase. The rest of the record consists of 7 share grants. Since January 2020: no purchases and 1 sale on the market.
The latest filing, published on 17 December 2020, reports an open-market sale of €1.1M in PDL Biopharma, Inc. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Dominique Monnet
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
500,000 shares@ US$2.6033.2% of flowCommon stockSEC:0000882104-20-000210:0
672,505 shares@ US$3.5166.8% of flowCommon stockSEC:0000882104-20-000042:0
1,233,766 shares0Common stockSEC:0000882104-20-000046:0
1,233,766 shares0Common stockSEC:0000882104-20-000006:0
451,075 shares@ US$3.7224.1% of flowCommon stockSEC:0000882104-19-000038:0
431,317 shares@ US$3.7223.1% of flowCommon stockSEC:0000882104-19-000024:0
17,615 shares@ US$3.020.8% of flowCommon stockSEC:0000882104-18-000131:0
240,200 shares0Common stockSEC:0000882104-17-000091:0
8 of 8 declarations
